Naples Prognostic Score is an Independent Prognostic Factor in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma

References

• Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380(15):1450–1462. doi:10.1056/NEJMra1713263
   PubMed Web of Science ®Google Scholar
• Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S. Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg. 2015;261(5):947–955. doi:10.1097/SLA.0000000000000710
   PubMed Web of Science ®Google Scholar
• Lewis DR, Chen HS, Cockburn MG, et al. Early estimates of SEER cancer incidence, 2014. Cancer. 2017;123(13):2524–2534. doi:10.1002/cncr.30630
   PubMed Web of Science ®Google Scholar
• Ruiz-Margain A, Roman-Calleja BM, Moreno-Guillen P, et al. Nutritional therapy for hepatocellular carcinoma. World J Gastrointest Oncol. 2021;13(10):1440–1452. doi:10.4251/wjgo.v13.i10.1440
   PubMed Web of Science ®Google Scholar
• Yang YM, Kim SY, Seki E. Inflammation and liver cancer: molecular mechanisms and therapeutic targets. Semin Liver Dis. 2019;39(1):26–42. doi:10.1055/s-0038-1676806
   PubMed Web of Science ®Google Scholar
• van der Windt DJ, Sud V, Zhang H, et al. Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis. Hepatology. 2018;68(4):1347–1360. doi:10.1002/hep.29914
   PubMed Web of Science ®Google Scholar
• Alberino F, Gatta A, Amodio P, et al. Nutrition and survival in patients with liver cirrhosis. Nutrition. 2001;17(6):445–450. doi:10.1016/S0899-9007(01)00521-4
   PubMed Web of Science ®Google Scholar
• Fujiwara N, Nakagawa H, Kudo Y, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol. 2015;63(1):131–140. doi:10.1016/j.jhep.2015.02.031
   PubMed Web of Science ®Google Scholar
• Perisetti A, Goyal H, Yendala R, Chandan S, Tharian B, Thandassery RB. Sarcopenia in hepatocellular carcinoma: current knowledge and future directions. World J Gastroenterol. 2022;28(4):432–448. doi:10.3748/wjg.v28.i4.432
   PubMed Web of Science ®Google Scholar
• Harimoto N, Yoshizumi T, Sakata K, et al. Prognostic significance of preoperative controlling nutritional status (CONUT) score in patients undergoing hepatic resection for hepatocellular carcinoma. World J Surg. 2017;41(11):2805–2812. doi:10.1007/s00268-017-4097-1
   PubMed Web of Science ®Google Scholar
• Tsunematsu M, Haruki K, Fujiwara Y, et al. Preoperative controlling nutritional status (CONUT) score predicts long-term outcomes in patients with non-B non-C hepatocellular carcinoma after curative hepatic resection. Langenbecks Arch Surg. 2021;406(1):99–107. doi:10.1007/s00423-020-01987-9
   PubMed Web of Science ®Google Scholar
• Liang X, Liangliang X, Peng W, et al. Combined prognostic nutritional index and albumin-bilirubin grade to predict the postoperative prognosis of HBV-associated hepatocellular carcinoma patients. Sci Rep. 2021;11(1):14624. doi:10.1038/s41598-021-94035-5
   PubMed Web of Science ®Google Scholar
• Fan X, Chen G, Li Y, et al. The preoperative prognostic nutritional index in hepatocellular carcinoma after curative hepatectomy: a retrospective cohort study and meta-analysis. J Invest Surg. 2021;34(8):826–833. doi:10.1080/08941939.2019.1698679
   PubMed Web of Science ®Google Scholar
• Sun Y, Zhang L. The clinical use of pretreatment NLR, PLR, and LMR in patients with esophageal squamous cell carcinoma: evidence from a meta-analysis. Cancer Manag Res. 2018;10:6167–6179. doi:10.2147/CMAR.S171035
   PubMed Web of Science ®Google Scholar
• Feng JF, Sheng C, Zhao Q, Chen P. Prognostic value of mean platelet volume/platelet count ratio in patients with resectable esophageal squamous cell carcinoma: a retrospective study. PeerJ. 2019;7:e7246. doi:10.7717/peerj.7246
   PubMed Web of Science ®Google Scholar
• Castillo-Martinez L, Castro-Eguiluz D, Copca-Mendoza ET, et al. Nutritional assessment tools for the identification of malnutrition and nutritional risk associated with cancer treatment. Rev Invest Clin. 2018;70(3):121–125. doi:10.24875/RIC.18002524
   PubMedGoogle Scholar
• Lucca I, de Martino M, Hofbauer SL, Zamani N, Shariat SF, Klatte T. Comparison of the prognostic value of pretreatment measurements of systemic inflammatory response in patients undergoing curative resection of clear cell renal cell carcinoma. World J Urol. 2015;33(12):2045–2052. doi:10.1007/s00345-015-1559-7
   PubMed Web of Science ®Google Scholar
• Galizia G, Lieto E, Auricchio A, et al. Naples prognostic score, based on nutritional and inflammatory status, is an independent predictor of long-term outcome in patients undergoing surgery for colorectal cancer. Dis Colon Rectum. 2017;60(12):1273–1284. doi:10.1097/DCR.0000000000000961
   PubMed Web of Science ®Google Scholar
• Feng JF, Zhao JM, Chen S, Chen QX. Naples prognostic score: a novel prognostic score in predicting cancer-specific survival in patients with resected esophageal squamous cell carcinoma. Front Oncol. 2021;11:652537. doi:10.3389/fonc.2021.652537
   PubMed Web of Science ®Google Scholar
• Nakagawa N, Yamada S, Sonohara F, et al. Clinical Implications of Naples Prognostic Score in Patients with Resected Pancreatic Cancer. Ann Surg Oncol. 2020;27(3):887–895. doi:10.1245/s10434-019-08047-7
   PubMed Web of Science ®Google Scholar
• Xuan J, Peng J, Wang S, Cai Y. Prognostic significance of Naples prognostic score in non-small-cell lung cancer patients with brain metastases. Future Oncol. 2022;18(13):1545–1555. doi:10.2217/fon-2021-1530
   PubMed Web of Science ®Google Scholar
• Inokuchi S, Itoh S, Yoshizumi T, et al. Prognostic significance of systemic inflammation score in patients who undergo hepatic resection for hepatocellular carcinoma. Langenbecks Arch Surg. 2021;406(3):773–779. doi:10.1007/s00423-021-02103-1
   PubMed Web of Science ®Google Scholar
• Abe T, Nakata K, Kibe S, et al. Prognostic value of preoperative nutritional and immunological factors in patients with pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2018;25(13):3996–4003. doi:10.1245/s10434-018-6761-6
   PubMed Web of Science ®Google Scholar
• Pokharel N, Katwal G, Adhikari SK. Comparison of preoperative nutritional risk index and body mass index for predicting immediate postoperative outcomes following major gastrointestinal surgery: cohort-study. Ann Med Surg. 2019;48:53–58. doi:10.1016/j.amsu.2019.10.011
   PubMed Web of Science ®Google Scholar
• Wang D, Hu X, Xiao L, et al. Prognostic nutritional index and systemic immune-inflammation index predict the prognosis of patients with HCC. J Gastrointest Surg. 2021;25(2):421–427. doi:10.1007/s11605-019-04492-7
   PubMed Web of Science ®Google Scholar
• Tokunaga R, Sakamoto Y, Nakagawa S, et al. CONUT: a novel independent predictive score for colorectal cancer patients undergoing potentially curative resection. Int J Colorectal Dis. 2017;32(1):99–106. doi:10.1007/s00384-016-2668-5
   PubMed Web of Science ®Google Scholar
• Cengiz O, Kocer B, Surmeli S, Santicky MJ, Soran A. Are pretreatment serum albumin and cholesterol levels prognostic tools in patients with colorectal carcinoma? Med Sci Monit. 2006;12(6):CR240–247.
   PubMed Web of Science ®Google Scholar
• Oliver MF. Serum cholesterol--The knave of hearts and the joker. Lancet. 1981;2(8255):1090–1095. doi:10.1016/S0140-6736(81)91286-1
   PubMed Web of Science ®Google Scholar
• Kritchevsky SB, Kritchevsky D. Serum cholesterol and cancer risk: an epidemiologic perspective. Annu Rev Nutr. 1992;12:391–416. doi:10.1146/annurev.nu.12.070192.002135
   PubMed Web of Science ®Google Scholar
• Jiang SS, Weng DS, Jiang L, et al. The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma. J Cancer. 2016;7(6):626–632. doi:10.7150/jca.13837
   PubMed Web of Science ®Google Scholar
• Nishijima TF, Muss HB, Shachar SS, Tamura K, Takamatsu Y. Prognostic value of the lymphocyte-to-monocyte ratio in patients with solid tumors: a systematic review and meta-analysis. Cancer Treat Rev. 2015;41(10):971–978. doi:10.1016/j.ctrv.2015.10.003
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–867. doi:10.1038/nature01322
   PubMed Web of Science ®Google Scholar
• Rodriguez PC, Quiceno DG, Zabaleta J, et al. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res. 2004;64(16):5839–5849. doi:10.1158/0008-5472.CAN-04-0465
   PubMed Web of Science ®Google Scholar
• Pillay J, Kamp VM, van Hoffen E, et al. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest. 2012;122(1):327–336. doi:10.1172/JCI57990
   PubMed Web of Science ®Google Scholar
• Hiraoka N. Tumor-infiltrating lymphocytes and hepatocellular carcinoma: molecular biology. Int J Clin Oncol. 2010;15(6):544–551. doi:10.1007/s10147-010-0130-1
   PubMed Web of Science ®Google Scholar
• Schobert IT, Savic LJ, Chapiro J, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE. Eur Radiol. 2020;30(10):5663–5673. doi:10.1007/s00330-020-06931-5
   PubMed Web of Science ®Google Scholar
• Johnson PJ, Dhanaraj S, Berhane S, Bonnett L, Ma YT. The prognostic and diagnostic significance of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study. Br J Cancer. 2021;125(5):714–716. doi:10.1038/s41416-021-01445-3
   PubMed Web of Science ®Google Scholar
• Liang W, Ferrara N. The complex role of neutrophils in tumor angiogenesis and metastasis. Cancer Immunol Res. 2016;4(2):83–91. doi:10.1158/2326-6066.CIR-15-0313
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–444. doi:10.1038/nature07205
   PubMed Web of Science ®Google Scholar
• Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol. 2017;14(7):399–416. doi:10.1038/nrclinonc.2016.217
   PubMed Web of Science ®Google Scholar
• Galdiero MR, Garlanda C, Jaillon S, Marone G, Mantovani A. Tumor-associated macrophages and neutrophils in tumor progression. J Cell Physiol. 2013;228(7):1404–1412. doi:10.1002/jcp.24260
   PubMed Web of Science ®Google Scholar
• Lin ZX, Ruan DY, Li Y, et al. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection. World J Gastroenterol. 2015;21(38):10898–10906. doi:10.3748/wjg.v21.i38.10898
   PubMed Web of Science ®Google Scholar
• Jin J, Wang H, Peng F, et al. Prognostic significance of preoperative Naples prognostic score on short- and long-term outcomes after pancreatoduodenectomy for ampullary carcinoma. Hepatobiliary Surg Nutr. 2021;10(6):825–838. doi:10.21037/hbsn-20-741
   PubMed Web of Science ®Google Scholar
• Li Q, Cong R, Wang Y, et al. Naples prognostic score is an independent prognostic factor in patients with operable endometrial cancer: results from a retrospective cohort study. Gynecol Oncol. 2021;160(1):91–98. doi:10.1016/j.ygyno.2020.10.013
   PubMed Web of Science ®Google Scholar
• Kong W, Yang M, Zhang J, et al. Prognostic value of inflammation-based indices in patients with resected hepatocellular carcinoma. BMC Cancer. 2021;21(1):469. doi:10.1186/s12885-021-08153-4
   PubMed Web of Science ®Google Scholar
• Tao Y, Li Y, Liu X, Deng Q, Yu Y, Yang Z. Nonsteroidal anti-inflammatory drugs, especially aspirin, are linked to lower risk and better survival of hepatocellular carcinoma: a meta-analysis. Cancer Manag Res. 2018;10:2695–2709. doi:10.2147/CMAR.S167560
   PubMed Web of Science ®Google Scholar